Taysha Gene Therapies, Inc. TSHA

Set alert

4.36 USD +0.27 (+6.60%)

At closeNov 4, 2026, 4:01 PM EST

4.36 0.00 0.00%

After hours · Nov 4, 4:01 PM ET

4.01 Day range 4.38

3.46 52-week range 7.30

Held by insiders 9.45%

Held by institutions 94.56%

Float held by institutions 104.43%

Institutions 277

Top institutional holders
Holder	% held	Shares	Value	Reported
Avoro Capital Advisors LLC	7.33%	23,888,888	104.16M	Jun 29, 2026
RA Capital Management, L.P.	7.23%	23,555,648	102.70M	Jun 29, 2026
Goldman Sachs Group Inc	6.97%	22,713,118	99.03M	Jun 29, 2026
Blackrock Inc.	6.35%	20,691,927	90.22M	Jun 29, 2026
Vestal Point Capital, LP	5.96%	19,415,000	84.65M	Jun 29, 2026
Morgan Stanley	5.06%	16,487,479	71.89M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.80%	9,138,043	39.84M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.12%	6,895,325	30.06M	Sep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.58%	5,138,803	22.41M	Sep 29, 2026
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund	1.28%	4,170,948	18.19M	Aug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	0.93%	3,044,554	13.27M	Jun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.81%	2,626,937	11.45M	Aug 30, 2026

TSHA insiders
Insider	Relation	Latest transaction	Date	Shares held
ALAM KAMRAN	Chief Financial Officer	Sale	Feb 3, 2026	1,442,130
DONENBERG PHILLIP BRIAN	Director	Stock Award(Grant)	May 31, 2026	241,289
LONG ALISON S	Director	Stock Award(Grant)	May 31, 2026	127,178
MANNING PAUL B.	Beneficial Owner of more than 10% of a Class of Security	Purchase	May 29, 2025	0
NAGENDRAN SUKUMAR	Officer and Director	Sale	Jul 9, 2026	936,410
NOLAN SEAN PATRICK	Chief Executive Officer	Sale	Jan 25, 2026	4,443,800

Held by funds